Atrasentan in Treating Patients With Prostate Cancer
NCT00046943
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
atrasentan hydrochloride
Sponsor
Abbott